Home › Trials › NCT06919341

Registry for patients with Primary Immune Thrombocytopenia in Spain

RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia

Observational Fundación Española de Hematología y Hemoterapía · NCT06919341

This study is collecting information from patients with Primary Immune Thrombocytopenia in Spain to better understand the condition and improve how it's treated.

Quick facts

Study typeObservational
Enrollment1000 (estimated)
Ages2 Months and up
SexAll
SponsorFundación Española de Hematología y Hemoterapía Academic / other
Locations36 sites (A Coruña, A Coruña and 35 other locations)
Trial IDNCT06919341 on ClinicalTrials.gov

What this trial studies

This observational registry aims to gather comprehensive epidemiological data on Primary Immune Thrombocytopenia (PIT) and other immune-related thrombocytopenias in Spain. It will include patients of all ages who have been diagnosed with PIT or similar conditions, focusing on their clinical characteristics and treatment histories. The study seeks to enhance understanding of the disease's prevalence and incidence, which is currently lacking in the region. By collecting data from various hospitals, the registry will help characterize the patient population and improve future management strategies.

Who should consider this trial

Good fit: Ideal candidates include children as young as 2 months and adults diagnosed with PIT or other immune-related thrombocytopenias with a platelet count below 100 x 10^9/L.

Not a fit: Patients who do not meet the inclusion criteria or those with thrombocytopenia of non-immune origin may not benefit from this registry.

Why it matters

Potential benefit: If successful, this registry could lead to improved diagnosis and treatment options for patients with Primary Immune Thrombocytopenia.

How similar studies have performed: While there is limited data on similar registries, the approach of collecting epidemiological data on PIT is essential and has shown promise in other regions.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Children as young as 2 months of age and adults in follow-up since 2015 (irrespective of date of diagnosis) with the diagnostic presumption of PIT or other thrombocytopenia of probable immune origin defined as a platelet count \< 100 x 109/L.
* Patients who have given written informed consent. In the case of deceased patients, the data will be included in the registry and the investigator will record the impossibility of collecting patient's informed consent form due to death. Only patients deceased after December 31 2015, will be included

Exclusion Criteria:

* Patients who, at the investigator's discretion, do not meet the conditions for inclusion in the study

Where this trial is running

A Coruña, A Coruña and 35 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions ITP - Immune ThrombocytopeniaPrimary Immune ThrombocytopeniaITPPTITrombocitopenia inmune primariaPrimary Inmune Thrombocytopenia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.